Targeted Cationic Liposomes, Technologies, and Developments

El-Aneed,Anas;

Targeted Cationic Liposomes, Technologies, and Developments

December 2, 2003

By Anas El-Aneed

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-12-02-2003

Volume 27

Issue 12

The author provides a brief review of tumor-specific and liver-targeted cationic liposomes and the strategies for the development of liposome-ligand complexes.

External Link - article-78329.pdf

Articles in this issue

December 2003

All Signs Indicate a Strong 2004 for Contract Services

Behavior of Uptake of Moisture by Drugs and Excipients

A State of Revision: USP's Guideline for the Submission of Requests for Revision

Targeted Cationic Liposomes, Technologies, and Developments

Sixth Annual International Employment Survey: Staying the Course

Drug Pricing Concerns Shape Policy Decisions in 2003

In the Spotlight--January 2004

December 2003

Related Content

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney

June 30th 2025

Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

3D Rendering of CAR - Chimeric Antigen Receptor Between T-Cell and Cancer Cell | Image Credit: © Alpha Tauri 3D - stock.adobe.com

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments

Patrick Lavery

June 26th 2025

Article

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024

Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.